Skip to main content
. 2013 Sep 17;2013:231956. doi: 10.1155/2013/231956

Table 3.

Demographic and drug use characteristics at baseline (n = 24).

Methadone (MTD) n = 11 Buprenorphine (BUP) n = 13 P-value
Male (n (%)) 9 (81%) 11 (85%) n.s.
African American (n (%)) 8 (73%) 7 (54%) n.s.
Age (mean ± SD) 43.5 ± 8.7 40.5 ± 6.8 n.s.
Education in years (median (IQR)) 12 (12,12) 12 (11, 12) n.s.
Married (n (%)) 0 (0%) 3 (30%) n.s.
Days paid for work in last 30 (mean ± SD) 3.6 ± 8.4 9.2 ± 8.9 n.s.
Usual full-time employment (n (%)) 4 (44%) 3 (30%) n.s.
Days cocaine use in last 30 (median (IQR)) 0 (0, 15) 0.5 (0, 4) n.s.
Days heroin use in last 30 (mean ± SD) 19.6 ± 10.4 13.5 ± 10.4 n.s.
Days other opiate use in last 30 (mean ± SD) 4.1 ± 6.0 17.7 ± 11.6 <0.005
Days alcohol use in last 30 (median (IQR)) 0 (0, 0) 1 (0, 3) n.s.
Days alcohol intox last 30 (median (IQR)) 0 (0, 0) 0.5 (0, 3) n.s.
Years cocaine use (median (IQR)) 10 (1,20) 1 (0, 7) n.s.
Years heroin use (mean ± SD) 17.9 ± 12.0 12.3 ± 9.3 n.s.
Years other opiate use (median (IQR)) 0 (0,2) 1 (0,7) n.s.
Years alcohol use (median (IQR)) 4 (0,4) 1 (0,13) n.s.

Categorical variables (gender, ethnicity, marital status, and employment status) were analyzed using Fisher's exact test. Continuous variables were analyzed using student t-tests (normally distributed) and Wilcoxon rank sum tests (nonnormally distributed).